brand-logo

Accelagen Staff Announcement: Sian Gilmour

Accelagen Staff Announcement: Sian Gilmour

Sian

One of the things we love most about our work is helping people to learn and develop their careers along whatever path they are inspired to pursue.

Today we are excited to share that we have appointed an exciting emerging talent in Clinical Research Associate, Sian Gilmour.

Sian Gilmour is an impressive young professional who has quickly advanced her career in the Clinical Research and Pharmaceutical industry.

Completing a degree in Animal and Veterinary Sciences at La Trobe with a distinction grade level, Sian was inspired to explore human clinical studies thanks to her mother who works as a study coordinator at Royal Melbourne Hospital.

In 2019, she secured her first role at global CRA, PPD, as a Project Assistant, and was soon promoted to Remote Site Monitor Level 1 in 2020. In 2021, she was again promoted to Remote Site Manager Level 2, an experience that exposed her to trials from all different indications including oncology, neuroscience, cardiovascular and general medicine, from startup, through to recruitment and maintenance phase.

While in training to become a CRA, Sian was introduced to Accelagen and we knew immediately that she was a great fit for our growing local business. A hard-working and collaborative team player, her values reflect our own.

Sian is now a CRA Level 2 overseeing on-site monitoring for Phase 1 trials in different therapeutic areas, including rare diseases. Her role includes everything from assisting sites, to working directly with the clients, undertaking SOP management, creating and editing trial documents, and more. Her work ethic, ambition, enthusiasm, and team spirit are an asset to our business.

Welcome to the team, Sian!

You might also like...​

Welcoming our new Business Planning and Analysis Manager

Welcoming our new Business Planning and Analysis Manager   Accelagen is delighted to announce David Stella as our new Business Planning and Analysis Manager. With over a decade of experience in financial planning and analysis, David joins us from IDP Education, an ASX top 100 company, where he excelled in financial reporting and business analysis. […]

Read More
Hands operating syringe
Accelagen accelerates time to market for European clients: Potentially best-in-class study for Treatment of BKV Infection sees exciting results

Accelagen accelerates time to market for European clients: Potentially best-in-class study for Treatment of BKV Infection sees exciting results Local CRO, Accelagen, attracts innovative European drug and antibody developers to trial in Australian market Engaged by world-renowned European clients and collaborators, Memo Therapeutics AG (“MTx”) based in Switzerland, and Vakzine Projekt Management GmbH (VPM) based […]

Read More
Amritha
Accelagen Staff Announcement: Amritha Vangur

Accelagen Staff Announcement: Amritha Vangur The Accelagen family is growing…again! Today we are thrilled to announce that Amritha Vangur has rejoined our team as Clinical Research Associate. Amritha first worked at Accelagen in 2019. The company was in its infancy at the time, with a small, tight-knit team. Shortly after joining, Amritha travelled overseas and […]

Read More